Download the Complete Report Here By Rayk Riechmann At the end of the day, pressure is what turns a chunk of coal into a diamond. That’s how savvy investors might look at Alliance Resource Partners, L.P. (NasdaqGS: ARLP) which reported...

Contact: Executives-Edge.com Rayk@capmarketsmedia.com

By Daniella Parra Health tech company Helfie AI has appointed Stefan Kulik as Chief Operating Officer and Rania Awad as Chief Strategy Officer, strengthening its leadership team as it prepares for the global consumer launch of its AI-powered mobile health...

By Daniella Parra Recordati, an international pharmaceutical company said its consolidated net revenue rose 12% to  €1.3 billion in the first half of 2025. Rare Diseases revenue was €515.7 million for the first half of 2025, up 29.2% as compared...

By Karen Roman NanoCell Therapeutics, Inc. said it published data in the Journal for ImmunoTherapy of Cancer showing the results of NCtx, its targeted lipid nanoparticle delivery system. The study is the first successful demonstration of non-viral DNA delivery to...

By Karen Roman ReAlta Life Sciences, Inc. said it designated Ellen Lubman as Chief Business Officer to supervise business development, capital formation and corporate strategy. Ms. Lubman has nearly 25 years of experience across small to large-cap private and public...

By Daniella Parra Volcon (NASDAQ: VLCN) said it closed a $500 million private placement and will allocate over 95% of the proceeds to Bitcoin purchases. The company, which already holds 280.14 BTC, is rebranding as Empery Digital, Inc. with a...

By Daniella Parra ReAlta Life Sciences said Pegtarazimod is being evaluated in a Phase 2 trial across 13 U.S. NICUs for newborns with moderate to severe neuroinflammation in HIE. The company said that newborn rats treated with pegtarazimod after oxygen...

By Daniella Parra Vinson & Elkins has expanded its global aviation finance practice with the addition of Harry Upcott as a partner in its London office, it said. Upcott brings extensive experience advising on complex aviation and satellite financing, leasing,...

  By Daniella Parra Lisata Therapeutics said it has been granted a new composition of matter patent for its lead drug candidate, certepetide, offering the highest level of IP protection by covering the drug’s unique chemical structure, how it’s made,...